StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Jardiance by Year

Jardiance — Worldwide revenue growth YoY (%) [Q1–Q3 10-Q & FY through FY2024] (%)

Eli Lilly Jardiance: 22.0% in FY2024, down 11.0 pts from a year earlier. That is the lowest of the 8 years on record here. No newer figure appears in the documents we track.

Latest, FY2024
22.0%
Period ended Dec 31, 2024
Change on a year earlier
-11.0 pts
33.0% in FY2023
History
8 years
Since FY2017
Sources
8
Documents cited below

Where the FY2024 figure comes from

“|| Jardiance (1) | 1,597.5 | 1,743.4 | 3,340.9 | 2,744.7 | 22”

Source: Form 10-K FY2024 (filed 2025-02-19) ↗

Reported in Form 10-Q MD&A & Form 10-K through FY2024.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedJardiance — Worldwide revenue growth YoY (%) [Q1–Q3 10-Q & FY through FY2024] (%)Year on yearSource
FY2024Dec 31, 202422.0%-11.0 ptsForm 10-K FY2024 (filed 2025-02-19) ↗
FY2023Dec 31, 202333.0%-6.0 ptsForm 10-K FY2023 (filed 2024-02-21) ↗
FY2022Dec 31, 202239.0%+10.0 ptsForm 10-K FY2022 (filed 2023-02-22) ↗
FY2021Dec 31, 202129.0%+7.0 ptsForm 10-K FY2021 (filed 2022-02-23) ↗
FY2020Dec 31, 202022.0%-25.0 ptsForm 10-K FY2020 (filed 2021-02-17) ↗
FY2019Dec 31, 201947.0%0.0 ptsForm 10-K FY2019 (filed 2020-02-19) ↗
FY2018Dec 31, 201847.0%-75.0 ptsForm 10-K FY2018 (filed 2019-02-19) ↗
FY2017Dec 31, 2017122.0%–Form 10-K FY2017 (filed 2018-02-20) ↗

Cite this data

StockData. (2026). Eli Lilly Jardiance (%), annual FY2017–FY2024 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-jardiance-yoy

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.